# Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma

> **NCT03817307** · NA · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** USPIO-enhanced MRI

## Key facts

- **NCT ID:** NCT03817307
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-20
- **Primary completion:** 2022-06-01
- **Final completion:** 2023-04
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817307, "Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03817307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*